Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001291010 | SCV003825312 | pathogenic | Mucopolysaccharidosis, MPS-II | 2022-04-01 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV001291010 | SCV005089266 | pathogenic | Mucopolysaccharidosis, MPS-II | 2024-06-07 | criteria provided, single submitter | literature only | Null variant (PVS1_VeryStrong), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Strong) |
Laboratory of Inherited Metabolic Diseases, |
RCV001291010 | SCV001450613 | pathogenic | Mucopolysaccharidosis, MPS-II | no assertion criteria provided | research |